Lanean...
Thiazide Exposure and Cardiovascular Risk in Type 2 Diabetes: A Point of Clarification
A recently published analysis in Hypertension suggests that thiazide use, versus non-use, is associated with excess risk of adverse cardiovascular outcomes in patients with diabetes enrolled in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Herein, we replicate these findings...
Gorde:
| Argitaratua izan da: | Hypertension |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7035168/ https://ncbi.nlm.nih.gov/pubmed/32008437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14447 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|